Tirzepatide in PWS, HO and GNSO — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Tirzepatide in PWS, HO and GNSO — Stella

Recruiting

Back to Prader-Willi Syndrome trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

United States

Children's Minnesota, Saint Paul, Minnesota

Vanderbilt University Medical Center, Nashville, Tennessee

Seattle Children's Hospital, Seattle, Washington

Key details

Phase

Post-approval study

Sponsor

Grace Kim

Collaborators

Vanderbilt University Medical Center, Children's Hospitals and Clinics of Minnesota

Enrollment target

~36 participants

Started

May 2025

Primary completion

June 2026

Age range

18 Years – 26 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov